Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long vs short course recombinant human brain natriuretic peptide in acute heart failure
ChiCTR2300069664Phase 4Recruiting
- Sponsor
- Beijing Hospital
- Start
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of nesiritide in Acute Heart Failure (AHF) (2 arms), sponsored by Beijing Hospital. Primary endpoints: Clinical situation and Assessment of cardiac and renal functions. Started Dec 2021; status: recruiting.
02
Drugs
nesiritide
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on ChiCTR2300069664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069664.